David Michael Clark - 14 Jan 2022 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role: Chief People Officer
Signature: /s/ Christian Formica, Attorney-in-Fact
Issuer symbol: FOLD
Transactions as of: 14 Jan 2022
Net transactions value: -$133,563
Form type: 4
Filing time: 19 Jan 2022, 17:46:37 UTC
Previous filing: 04 Jan 2022
Next filing: 09 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FOLD	Common Stock	Award		+59,071	+40%		207,313	14 Jan 2022	Direct	F1, F2
transaction	FOLD	Common Stock	Award		+32,235	+16%		239,548	14 Jan 2022	Direct	F3
transaction	FOLD	Common Stock	Tax liability	$133,563	-12,684	-5.3%	$10.53	226,864	14 Jan 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FOLD	Stock Options (right to buy)	Award	$0	+108,266		$0.000000	108,266	14 Jan 2022	Common Stock	108,266	$12.11	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock.
F2	The Restricted Stock Units will vest in four equal annual installments beginning on January 3, 2023.
F3	Granted for the achievement of the 2019 PRSU TSR goal as determined by the Board of Directors.
F4	These options vest and become exercisable in a series of installments over a four year period with 25% vesting on January 3, 2023 and the remaining 75% vesting ratably each month thereafter.